The US FDA had issued a warning letter to Sun Pharma’s subsidiary Caraco Pharmaceutical Laboratories on Oct 31, 2008. The letter is now available on the FDA site detailing the reasons why the warning was issued. It points out deviations from current Good Manufacturing Practice (CGMP) regulations for medicines. These deviations were detected in an inspection between May 1 to June 11 2008, and are mainly due to issues related to quality control. Continue Reading →
Pharmaceutical
Recent Posts
Sun Pharmaceuticals to pay 2x revenues to acquire Chattem?
|
Sun Pharmaceuticals has acquired Chattem Chemicals Inc, a US-based pharmaceutical company, which makes $26mn in revenues from selling bulk drugs. Chattem had been acquired by Elcat Inc in 1995 from Chattem Inc, for $25mn. Sun has not disclosed the acquisition price but we will try to make some educated guesses.